OPKO Health Inc. (OPK)

3.65
NASDAQ : Health Technology
Prev Close 3.65
Day Low/High 0.00 / 0.00
52 Wk Low/High 2.66 / 7.25
Avg Volume 5.11M
Exchange NASDAQ
Shares Outstanding 559.47M
Market Cap 2.08B
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Constellation Brands, Zendesk, Box: 'Mad Money' Lightning Round

Constellation Brands, Zendesk, Box: 'Mad Money' Lightning Round

Jim Cramer weighs in on Constellation Brands, Zendesk, Box, Opko Health, Thor Industries, Hain Celestial Group and more.

Optimism and Banks Take the Lead: Cramer's 'Mad Money' Recap (Wednesday 5/9/18)

Optimism and Banks Take the Lead: Cramer's 'Mad Money' Recap (Wednesday 5/9/18)

Jim Cramer says oil soared, interest rates rose, and still the market cheered. What the heck is going on?

Noteworthy Wednesday Option Activity: OPK, MTCH, MACK

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in OPKO Health Inc , where a total of 23,287 contracts have traded so far, representing approximately 2.3 million underlying shares. That amounts to about 73.4% of OPK's average daily trading volume over the past month of 3.2 million shares.

OPK June 8th Options Begin Trading

Investors in OPKO Health Inc saw new options begin trading today, for the June 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for the new June 8th contracts and identified the following put contract of particular interest.

Interesting OPK Put And Call Options For December 21st

Investors in OPKO Health Inc saw new options begin trading this week, for the December 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Lennar, LG Homes, GrubHub, Sprint: 'Mad Money' Lightning Round

Lennar, LG Homes, GrubHub, Sprint: 'Mad Money' Lightning Round

Jim Cramer looks at Lennar, LG Homes, GrubHub, Sprint, Acadia Pharmaceuticals, Pilgrim's Pride, Opko Health and more.

A Flash Flood of Selling: Cramer's 'Mad Money' Recap (Thursday 4/19/18)

A Flash Flood of Selling: Cramer's 'Mad Money' Recap (Thursday 4/19/18)

Interest rates, inflation and bonds all add up, says Jim Cramer. And now, the trade war with China's getting ugly.

Interesting OPK Put And Call Options For May 25th

Investors in OPKO Health Inc saw new options become available today, for the May 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for the new May 25th contracts and identified one put and one call contract of particular interest.

Short Interest In OPKO Health Makes 13.7% Move

Short Interest In OPKO Health Makes 13.7% Move

The most recent short interest data has been released for the 02/28/2018 settlement date, which shows a 7,902,565 share increase in total short interest for OPKO Health Inc , to 65,405,998, an increase of 13.74% since 02/15/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

The Truth About Trade: Cramer's 'Mad Money' Recap (Friday 3/2/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Friday 3/2/18)

From corporate tax breaks to tariffs, Jim Cramer puts it in perspective and outlines your game plan for next week.

Snap, Vail Resorts, Raymond James: 'Mad Money' Lightning Round

Snap, Vail Resorts, Raymond James: 'Mad Money' Lightning Round

Jim Cramer spotlights Snap, Vail Resorts, Raymond James Financial, Senior Housing Properties Trust, Opko Health, Deere & Co., AFLAC, Seagate Technology.

OPKO Health Reports 2017 Fourth Quarter Business Highlights And Financial Results

OPKO Health Reports 2017 Fourth Quarter Business Highlights And Financial Results

Conference Call begins today at 4:30 p.m. Eastern Time

OPKO'S GeneDx Announces Research Collaboration With Radboud University Medical Center

OPKO'S GeneDx Announces Research Collaboration With Radboud University Medical Center

Aimed at identifying novel genes and pathways to help manage human genetic diseases

First Week Of OPK February 2018 Options Trading

First Week Of OPK February 2018 Options Trading

Investors in OPKO Health Inc saw new options begin trading this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

OPKO Health Enrolls First Patient In Phase 2B Study Of OPK88004 To Treat Benign Prostatic Hypertrophy

OPKO Health Enrolls First Patient In Phase 2B Study Of OPK88004 To Treat Benign Prostatic Hypertrophy

Enlarged Prostate Affects Approximately 50 Million Men in the U.S.

Home Depot, Lowe's, The Blackstone Group: 'Mad Money' Lightning Round

Home Depot, Lowe's, The Blackstone Group: 'Mad Money' Lightning Round

Jim Cramer highlights Home Depot, Lowe's, The Blackstone Group, Capital Senior Living, Cypress Semiconductor.

Fundamentals Drive This Rally: Cramer's 'Mad Money' Recap (Thursday 11/16/17)

Fundamentals Drive This Rally: Cramer's 'Mad Money' Recap (Thursday 11/16/17)

Jim Cramer says don't be too quick to ascribe today's gains just to tax reform. This rally was roaring well before that. Instead, credit Cisco and Wal-Mart Stores.

Xenetic Biosciences Reports 2017 Third Quarter Financial Results And Provides Corporate Update

Xenetic Biosciences Reports 2017 Third Quarter Financial Results And Provides Corporate Update

Xenetic Biosciences, Inc. (NASDAQ: XBIO) ("Xenetic" or the "Company"), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan...

Xenetic Biosciences Enters Into Sublicense Agreement Related To Its PolyXen™ Technology With Baxalta Inc., A Wholly-owned Subsidiary Of Shire Plc

Xenetic Biosciences Enters Into Sublicense Agreement Related To Its PolyXen™ Technology With Baxalta Inc., A Wholly-owned Subsidiary Of Shire Plc

Xenetic Biosciences, Inc. (NASDAQ: XBIO) ("Xenetic" or the "Company"), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan...

Xenetic Biosciences Appoints Jeffrey F. Eisenberg As Chief Executive Officer

Xenetic Biosciences Appoints Jeffrey F. Eisenberg As Chief Executive Officer

Xenetic Biosciences, Inc. (NASDAQ: XBIO) ("Xenetic" or the "Company"), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan...

TheStreet Quant Rating: D (Sell)